In a Phase 2 clinical trial published in the New England Journal of Medicine , the 12mg retatrutide group achieved a 24.2% least-squares mean reduction in body weight after 48 weeks under the specific conditions of that study
Excess carnitine released by hepatocytes prevents hepatitis B surface antigen (HBsAg) clearance through immunosuppression
Gastroparesis, with its symptoms of nausea, vomiting, bloating, and abdominal pain, can exacerbate the discomfort and decrease the quality of life
This deficiency can result from conditions such as pernicious anemia, certain gastrointestinal disorders, or a diet low in animal products
This method bypasses common absorption issues associated with oral B12 supplements, especially beneficial for individuals with gastrointestinal malabsorption disorders